Drug shortage
Dextrose Monohydrate 5% Injection · B. Braun Medical Inc.
FDA drug shortage · Current · updated Sep 22, 2026
Key facts
| Generic name | Dextrose Monohydrate 5% Injection |
|---|---|
| Company | B. Braun Medical Inc. |
| Presentation | Dextrose Monohydrate 5%, Injection, 5 g/100 mL (NDC 0264-7510-20) |
| Dosage form | Injection |
| Status | Current |
| Therapeutic category | Endocrinology/Metabolism Gastroenterology Other Pediatric |
| Package NDCs | 0264-7510-20 |
| First posted | Feb 14, 2022 |
| Last updated | Sep 22, 2026 |
At a glance
- 1–9 Package NDCs affected
- 10–99 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: